Zdrowie i gospodarka · 21/01/2010

FDA Releases Revised Guidance on Nonclinical Safety Studies for Human Clinical Trials and Marketing Authorization

The FDA has released a revised guidance document titled M3(R2) Nonclinical Safety Studies for Human Clinical Trials and Marketing Authorization for Pharmaceuticals, developed under the International Conference on Harmonisation, to streamline clinical trials and reduce animal testing.